Edition:
India

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

18.01USD
2:25am IST
Change (% chg)

$-1.03 (-5.41%)
Prev Close
$19.04
Open
$19.00
Day's High
$19.06
Day's Low
$17.87
Volume
103,722
Avg. Vol
218,058
52-wk High
$24.30
52-wk Low
$11.48

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.57 December 20 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 3
(2) OUTPERFORM 4 4 3 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.43 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 9 3.52 6.00 0.00 3.45
Quarter Ending Mar-19 3 4.13 6.00 1.10 0.00
Year Ending Dec-18 9 11.44 13.94 7.90 2.97
Year Ending Dec-19 9 15.01 24.00 1.00 3.47
Earnings (per share)
Quarter Ending Dec-18 9 -0.57 -0.44 -0.74 -0.27
Quarter Ending Mar-19 3 -0.58 -0.53 -0.63 -0.34
Year Ending Dec-18 9 -2.15 -1.98 -2.37 -1.90
Year Ending Dec-19 9 -2.21 -1.82 -2.84 -1.89

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 3.40 5.03 1.63 48.02
Quarter Ending Jun-18 6.47 2.87 3.59 55.57
Quarter Ending Mar-18 0.03 0.00 0.03 100.00
Quarter Ending Dec-17 0.02 0.00 0.02 100.00
Quarter Ending Sep-17 0.19 0.00 0.19 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3.52 3.52 3.95 4.45 3.45
Quarter Ending Mar-19 4.13 4.13 4.40 4.40 0.00
Year Ending Dec-18 11.44 11.44 10.24 11.16 2.97
Year Ending Dec-19 15.01 15.01 16.22 18.25 3.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 3
Quarter Ending Mar-19 0 0 0 1
Year Ending Dec-18 0 0 3 3
Year Ending Dec-19 0 0 1 2
Earnings